Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Pharm Pract. 2014 Apr;22(2):146-54. doi: 10.1111/ijpp.12046. Epub 2013 Jun 13.

Proactive clinical pharmacist interventions in critical care: effect of unit speciality and other factors.

Author information

  • 1Departments of Pharmacy and Critical Care, Sheffield Teaching Hospitals, Northern General Hospital, Sheffield, UK.

Abstract

BACKGROUND:

Clinical pharmacists working in critical-care areas have a beneficial effect on a range of medication-related therapies including improving medication safety, patient outcomes and reducing medicines' expenditure. However, there remains a lack of data on specific factors that affect the reason for and type of interventions made by clinical pharmacists, such as unit speciality.

OBJECTIVE:

To compare the type of proactive medicines-related interventions made by clinical pharmacists on different critical-care units within the same institution.

METHODS:

A retrospective evaluation of proactive clinical pharmacist recommendations, made in three separate critical-care areas. Intervention data were analysed over 18 months (general units) and 2 weeks for the cardiac and neurological units. Assessment of potential patient harm related to the medication interventions were made in the neurological and cardiac units.

KEY FINDINGS:

Overall, 5623, 211 and 156 proactive recommendations were made; on average 2.2, 3.8 and 4.6 per patient from the general, neurological and cardiac units respectively. The recommendations acceptance rate by medical staff was approximately 90% for each unit. The median potential severity of patient harm averted by the interventions were 3.6 (3; 4.2) and 4 (3.2; 4.4) for the neurological and cardiac units (P = 0.059). The reasons for, types and drug classification of the medication recommendations demonstrated some significant differences between the units.

CONCLUSIONS:

Clinical pharmacists with critical-care training make important medication recommendations across general and specialist critical-care units. The patient case mix and admitting speciality have some bearing on the types of medication interventions made. Moreover, severity of patient illness, scope of regular/routine specialist pharmacist service and support systems provided also probably affect the reason for these interventions.

© 2013 Royal Pharmaceutical Society.

KEYWORDS:

UK; clinical pharmacist; critical care; drug therapy; medicines reconciliation

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Write to the Help Desk